期刊文献+

子宫内膜异位症和子宫腺肌症脆性组氨酸三联体表达的意义 被引量:1

Expression of fragile histidine triad in endometriosis and adenomyosis
下载PDF
导出
摘要 目的:观察脆性组氨酸三联体(Fhit)蛋白在子宫内膜异位症(EM)和子宫腺肌症(AM)中表达的作用.方法:应用免疫组化SP法检测36例子宫内膜异位症(EM组)异位内膜、22例子宫腺肌症(AM组)在位内膜及15例子宫肌瘤患者子宫内膜(对照组)中Fhit蛋白的表达情况.结果:Fhit主要表达在腺体上皮细胞的胞质和胞膜;EM组和AM组的Fhit表达无显著性差异,明显低于对照组;各组子宫内膜Fhit表达在增生期和分泌期均无显著性差异(P>0.05);EM组在位内膜的Fhit表达在临床r-AFS不同期别中无显著性差异(P>0.05),但异位内膜的Fhit表达在不同r-AFS分期中差异显著(P<0.05),Fhit表达的阳性强度与r-AFS分期呈负相关(r=-0.40,P<0.05).结论:Fhit可能在子宫内膜异位症的发生、发展过程中起重要作用. AIM: To study the expression of fragile histidine triad (Fhit) in endometriosis ( EM ) and adenomyosis ( AM ). SP staining was used to examine the expression of Fhit in the ectopic endometrium of 36 cases of endometriosis ( EM group) and eutopic endometrium of 22 cases of adenomyosis(AM group), as well as endometrium of 15 cases of hysteromyoma( control group). RESULTS : Mean optical density(MOD) of EM group showed no difference from that of AM group (P 〉 0.05). Expression of Fhit of EM/AM endometrium was lower than that of normal endometrium significantly (P 〈 0.05). Fhit of eutopic and ectopic endometrium in proliferative phase showed no difference from that in secretory phase ( P 〉 0.05). Fhit of eetopic endometrium showed significant difference between different r-AFS stages ( P 〈 0.05 ). Negative correlation was found between Fhit expression and r-AFS stage ( r = - 0.40, P 〈 0.05). CONCLUSION: Fhit may play an important role in the development of endometriosis and adenomyosis.
出处 《第四军医大学学报》 北大核心 2008年第16期1476-1478,共3页 Journal of the Fourth Military Medical University
关键词 子宫内膜异位症 子宫腺肌症 脆性组氨酸三联体 endometriosis adenomyosis fhit
  • 相关文献

参考文献6

  • 1Ishii H, Dumon KR, Vecchione A, et al. Effect of adenovival transduction of the fragile histidine triad gene in the esophageal cancer cells[J]. Cancer Res, 2001,61(4) :1578 - 1584.
  • 2Harada T, Kaponis A, Iwabe T, et al. Apoptosis in human endometrium and endometriosis [ J ]. Hum Reprod Update, 2004,10 (1) : 29 - 38.
  • 3刘玉琴,高英敏,王秀华.子宫内膜癌组织中FHIT、MMP-2的表达与临床病理的相关性研究[J].实用妇产科杂志,2005,21(4):223-225. 被引量:7
  • 4郎景和.子宫内膜异位症的研究与设想[J].中华妇产科杂志,2003,38(8):478-480. 被引量:527
  • 5Sillem M, Prifti S, Koch A, et al. Regulation of matrix metalloproteinsses and their inhibitors in uterine endometrial cell of patients with and without endometriosis[ J]. Eur J Obstet Gynecol Peprod Biol,2002,95(2) :167 - 174.
  • 6Opalka B, Dickopp A, Kirch HC. Apoptotic genes in cancer therapy [J]. Cells Tissues Organs, 2002,172(2) :126 -132.

二级参考文献7

  • 1Hao XP, Willis JE, Pretlow TG, et al. Loss of Fragile histidine triad expression in colorectal carcinomas and premalignant lesions.Cancer Res, 2000,60(1):18~21.
  • 2Pekarsky Y,Zanesi N,Palamarchuk A,et al. Fhit from gene discovery to cancer treatment and prevention. The Lancet Oncology,2002,3(12):748~754.
  • 3Ozaki K,Enomoto T,Yosaino K,et al.Fhit alterations in endometrial carcinoma and hyperplasia Int. J Cancer,2000,85(3):306~312.
  • 4Hadaczek P,Gronwacel J,Chosia M, et al.Fhit protein expression in endometrial cancers no correlation with histologyical grade. Pol p Pathol,2001,52(4):199~203.
  • 5Tamakoshi K,Kikkawa F,Nawa A,et al.Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.Cancer.1995,76(12):2565~2571.
  • 6Iarlaro M,Loverro G,Vacca A,et al.Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma.Eur J Clin Invest.1999,29(9):793~801.
  • 7郭文萍,陈贵安,祝成,王红梅.基质金属蛋白酶及其组织抑制因子在子宫内膜癌中的表达及其意义[J].中华妇产科杂志,2002,37(10):604-607. 被引量:12

共引文献531

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部